Integro Theranostics is a clinical stage company developing fluorescent imaging agents and associated medical devices that enable surgeons to readily see and remove cancerous tissue. This accurate, real-time visualization of cancer tissue facilitates a more complete removal of cancer during surgery.
Integro Theranostics was born out of a collaboration between Kingdom Capital (values based private investment company) and Washington University School of Medicine.
We are combining the clinical infrastructure of a top research medical center, the technology of a world renowned scientist, and the resources of Kingdom Capital to commercialize this transformative technology and improve surgical outcomes for cancer patients.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 16052 Swingley Ridge Rd,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Chesterfield.
- HQ
- St. Louis, Missouri
Integro Theranostics Questions
Integro Theranostics's website is https://integrotheranostics.com/leadership
Integro Theranostics's LinkedIn profile is https://www.linkedin.com/company/integro-theranostics
Integro Theranostics has
6 employees.
View email and phone details for 6
employees at Integro Theranostics.
Integro Theranostics's industry is
Biotechnology Research
Integro Theranostics's top competitors are
Nukudo,
Cassidy Turley,
Bordo Ai,
Astrumu®,
Evolation Consulting,
Red Alpha,
Biblical Business Training - Bbt,
Red Alpha Cybersecurity,
Dart,
Kingdom Capital.
Integro Theranostics's categories are Biotechnology Research
Integro Theranostics's founding year is 2020
